Creo Medical Group PLC (AIM: CREO)

Market Cap	72.39M
Revenue (ttm)	30.30M
Net Income (ttm)	-22.40M
Shares Out	402.15M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	323,108
Average Volume	722,926
Open	18.77
Previous Close	19.00
Day's Range	18.00 - 19.48
52-Week Range	12.00 - 43.00
Beta	0.83
RSI	50.97
Earnings Date	May 12, 2025

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; M...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 287
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: CREO

Financial Performance

In 2023, Creo Medical Group's revenue was 30.80 million, an increase of 13.24% compared to the previous year's 27.20 million. Losses were -21.70 million, -19.33% less than in 2022.